Optiver Holding
ORIC icon

Optiver Holding’s Oric Pharmaceuticals ORIC Stock Holding History

Optiver Holding’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.44K Buy
508
+256
+102% +$2.91K ﹤0.01% 1333
2025
Q4 		$2.06K Sell
252
-362
-59% -$4.17K ﹤0.01% 2005
2025
Q3 		$7.37K Buy
+614
New +$6.46K ﹤0.01% 1483

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Optiver Holding's ORIC Position: Q1 2026 in Review

Optiver Holding increased its Oric Pharmaceuticals (ORIC) stake by 102% in Q1 2026, buying an estimated $2.91K and bringing the position to 508 shares worth $6.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

Optiver Holding first reported a position in ORIC in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.37K in Q3 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Optiver Holding held 508 shares of Oric Pharmaceuticals worth $6.44K as of Q1 2026.
  • Optiver Holding bought 256 Oric Pharmaceuticals shares in Q1 2026, an estimated $2.91K.
  • Oric Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1333 holding.
  • Optiver Holding first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Oric Pharmaceuticals position peaked at $7.37K in Q3 2025.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.